secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2023-11-06T23:59:59+00:00
Accession:  0001104659-23-114757
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Quoin to effect 1-for-60,000 reverse stock split on Nov 8; ADS ratio changes to 1:1
--------------------------------------------------------------------------------

- Reverse split of ordinary shares at 1-for-60,000 ratio effective November 8, 2023.
- Authorized ordinary share capital reduced from 6 trillion to 100 million shares.
- Each ADS will represent one ordinary share post-split (previously 60,000 ordinary shares).
- Shareholders approved three-year frequency for say-on-pay; board adopted that cycle.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923114757/0001104659-23-114757-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465923114757/tm2330024d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-114757

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer